ii. SC-Seq: RNA profiling at single cell resolution to study tumor evolution, test for placement on phenotypic continuum of dissemination
iii. Spatial Seq: Laser ablated, or spatial deconstruction by other means, to identify spatial correlates of altered transcriptome in the spheroid.
iv. Invasion Parametrization: Organoid characterization (e.g. shape analysis, biosensor activities) driven by microscopy for high throughput screening, or mechanistic insights into dissemination ( )
v. Intravital imaging: Owing to a predetermined site of orthotopic xenotransplant to study this stage, intravital imaging is useful in studying early disseminating events ( ; )
vi. Computational Modeling: Rich parameters are now available to mechanistically model signaling pathways to understand cellular state in the phenotypic continuum ( )
| i. Intravital imaging: Imaging live in an animal through a window (sometimes in reporter hosts) to observe interaction of disseminating cancer cells with the stromal compartment ( ) ii. Ligand-Receptor Association: Typically through SC-Seq, wherein expression of ligands and receptors could identify heterotypic interactions in stroma ( ) iii. Stromal invasion assays: Quantitative methods to systematically study genetic and environmental drivers of stromal invasion ( ) iv. Stromal secretome analysis: Single cell secretome analyses by immune and other cell type in stroma can reveal cancer-stroma crosstalk ( ; ) v. Spatiotemporal Computational Modeling: Heterotypic cellular interactions can be modeled using spatially defined modeling with partial differential equations, or cellular automatons ( ; ) |
| i. 3D vasculature models: Tissue models to study cancer-vasculature interactions( ) ii. Permeability measurements: Study effect of cancer secreted factors on vascular permeability in high throughput ( ; ) iii. Phenotypic screens of intravasation: Barcoded KO libraries selected for intravasation potential ( ; ) iv. Microfluidics: Approaches to mimic vasculature and lymphatics, and incorporate defined mechanical parameters into observation ( ) |
| i. Exosomes: Microvesicles secreted by cancer cells bearing microRNA and other components, which could prepare niches in other tissues for micrometastases ( ; ). ii. Highly multiplexed imaging cytometry: Spatially resolved histological analysis with CyTof( ). iii. Biomimetic niches: Biomaterial based approaches to study cancer cell interactions with perturbed environment mimicking premetastatic niches ( ) |
| i. Staging analyses by Genomics: Understanding tumor subtypes and staging by genomic profiling in comparison to histological profiling ( ; ; ; ) ii. SC-Seq/Metabolomics/Genomics: Characterization of the metastatic nodes at multiple granularities and scale can reveal the evolution of secondary node formation ( ; ) iii. Single cell secretome: Identifying the molecular communication between neighboring cells and metastatic cancer cells ( ; ) iv. MRS/PET: functional imaging can reveal environmental factors correlating with metastasis (Herzog et al.,2013; ) |
| i. Tissue/ whole organism multiplexed histology: Identifying dormant cells unaffected by therapy ( ; ) ii. SC-Seq: Comparative transcriptomics to reveal senescent, stem-like, or dormant cells( ; ) iii. In vitro, or ex-vivo models: Studying emergence of dormancy by ex-vivo tissue culture models ( ; ; ) iv. Mechanistic computational models: Cellular automata, and other models to predict emergence of a senescent phenotype ( ) v. Cell line variants: Selection of clones from metastatic sources showing latency ( ) |
| i. Multivariate statistical analysis and regimen optimization: Systemic variation of drug regimen, combination etc to study a response ( ; ) ii. Organs on chip: Miniature tissue mimetics to systemically test drug response in varied microenvironments ( ; ; ) iii. Cancer specific drug kinetics prediction: Systems analysis of drug response by simulating signaling or metabolic state of cells ( ; ) iv. Deep learning and machine learning: Artificial intelligence has found many applications in network analysis, compound property and prediction of drug activity ( ; ) |
Computational Systems Biology Approaches to Metastasis Research
The biological mechanisms underlying cancer metastasis occur at multiple biological scales. The ability to describe events across scales is needed to understand tumor cell dissemination in an integrated manner. For a metastatic tumor cell, these scales include genetic and epigenetic alterations, protein-protein interactions, and metabolic requirements, which together control various molecular signaling networks responsible for autonomous progression to metastasis. At the tissue or organ level, homotypic and heterotypic interactions between cells, and with the microenvironment further increase the complexity of the disease phenotype.
The multi-scale perspective of cancer metastasis requires an appreciation that the phenotypes at one scale are likely informed by regulatory events at other scales. Here we provide a perspective on some of the computational approaches used to model cancer metastasis, including emerging data analysis techniques that are becoming tools in the arsenal of many systems biologists.
Mechanistic Models of Metastasis – towards linking mechanisms at different scales
Computational biology provides mathematical frameworks that represent fundamental biological processes for the purposes of generating testable, and often non-intuitive predictions about disease mechanisms. An optimal computational model of metastasis will derive observations not accessible by current experimental technologies, inspire clinically important testable hypotheses, and facilitate deeper understanding of the mechanisms of metastasis. Metastasis operates across multiple spatial and temporal scales. Therefore, individual models constructed at one scale (for example, a static picture of gene regulatory networks operating within a cell, the dynamic simulation of a signaling pathway promoting cell motility, or the spatial representation of invasion of cancer cells into the stroma) will need to be integrated into a multiscale framework representative of a systems understanding of metastasis.
Mechanistic modeling based on ordinary or partial differential equations has been used to study various aspects of the metastatic processes, such as using the genetic, transcriptional and metabolic networks to build the signaling pathways leading to cell migration and invasion. The combination of experimental observations and differential equation based modeling of signal transduction has revealed mechanisms by which extracellular ligands promote tumor growth and invasion( Kirouac et al., 2013 ; Kochanczyk et al., 2017 ; Korkut et al., 2015 ; Park et al., 2017 ; Ryu et al., 2015 ). A generalized mathematical model of protein kinase signaling, crucial in regulating various steps of cancer metastasis, revealed that phosphatases have more pronounced effect than kinases on the rate of duration of signaling( Heinrich et al., 2002 ). On these lines, individual subsystems and processes have been successfully modeled in considerable detail. For example, a recent mechanistic model was able to predict the stability of a partial epithelial-mesenchymal transition (EMT) in vivo based upon the in silico prediction that additional molecular participants in the core EMT machinery must exist to promote hybrid EMT phenotypic behaviors( Jia et al., 2017 ; Jolly et al., 2016 ). A comprehensive model of the phosphoinositide pathway could contribute to the understanding of cell polarity and the initiation of chemotaxis and invasion( Olivenca et al., 2018 ). In this model, all species of the pathways are modeled, along with their spatial localization within the cell, suggesting strategies to control the activities of various molecular species within the pathway. Similarly, a dynamic model of hypoxia inducible factor-1 alpha (HIF-1a) based signaling has revealed key features of HIF-1a stabilization, and its effect on transcriptional activity of the cell( Nguyen et al., 2013 ).
Mechanistic models have provided detailed understanding of many signaling pathways, augmented by parallel developments in biosensors, activity reporters, microscopy, microfluidics etc. However, complex phenomena like metastasis involve interactions of many more molecular species than can be observed and modeled directly, and therefore more systems approaches are necessary which do not rely on detailed observations of all the molecular species involved in the described process. Large scale cell signaling networks with quantitative reaction constants could be used for the predictive modeling of metastasis. However, the development of such genome wide networks is limited both by the ability to simultaneously observe the activity of large numbers of signaling molecules, and the computational power required to infer and simulate these networks across cells and for extended periods of time. At the gene and transcript levels, most computational approaches are informed by large-scale ‘omics studies. Modeling of larger signaling networks may involve abstraction at a higher level, using methods such as Petri nets( Pennisi et al., 2016 ), Boolean networks( Lu et al., 2015 ; Steinway et al., 2014 ), Bayesian networks( Friedman et al., 2000 ) or systemic perturbation-effect networks( Korkut et al., 2015 ).
Reconstructed gene regulatory networks were used to identify the regulatory program inducing metastasis in breast cancer( Ahmad et al., 2012 ; Walsh et al., 2017 ), and the role of BACH1 in bone metastasis( Liang et al., 2012 ). Similarly, metabolomic networks can be modeled at the whole cell level using flux balance and constraint-based reconstruction and analysis (COBRA) methods( Becker et al., 2007 ), predicting the genetic bottlenecks within the energy utilization program of a cell. Such analyses have been used to infer the mechanism of the oncogenic Warburg effect for the pro-metastatic microRNA-122( Tsai et al., 2009 ), and identify the reprogramming of adaptive metabolic and transcriptomic profiles in metastatic cancer stem cells( Aguilar et al., 2016 ; Wu et al., 2017 ).
A crucial feature of cancer metastasis, and many other biological processes, is the existence of biological hierarchies, or scales. To accommodate hierarchies inherent in cancer metastasis, more discrete models have been employed, including cellular automaton and other agent-based modeling approaches. Cellular automata models typically involve two- or multi-dimensional lattice of entities with a finite number of states, wherein latticed entities can interact with each other through an iterative process defined by a fixed set of rules. The automaton also lends itself to integrating with ODE based models within each entity, referred to as Hybrid Cellular Automaton Models. Similarly, agent based computational modeling has been used to model biological systems wherein each biological entity is referred to as an agent, with a set of attributes, which interact in a rule framework. Agent-based computational modeling of the tumor microenvironment that incorporates spatial diffusion of oxygen, nutrients and cytokines offers a platform for high-throughput hypothesis testing in silico and can help to explain intra-tumoral heterogeneity, non-uniform drug transport, and disparate therapeutic response under hypoxic and low pH conditions( Waclaw et al., 2015 ),( Ibrahim-Hashim et al., 2017 ; Robertson-Tessi et al., 2015 ). Agent based models allow easy compartmentalization, quintessential in biological systems at all scales, and incorporate the complexity of association and dissociation between biological entities( Blinov et al., 2017 ). As an example, an agent based simulator to model 3D multicellular systems has been created incorporating biophysical principles( Ghaffarizadeh et al., 2018 ). Another model, combined with spatial data generated from microfluidic metabolic secretion detection chambers showed that spatial organization of cells in a tumor creates spatial metabolic signatures, which drive macrophage specification and angiogenesis( Carmona-Fontaine et al., 2017 ). Agent based models can also be utilized to test hypotheses which are otherwise difficult to access experimentally. For example, competing hypotheses of self-seeding versus primary metastatic seeding were tested using agent based models: where circulating tumor cells repopulate the primary tumor, or secondary seeding: where metastasized cells from primary tumor form secondary nodes which return back to the primary tumor via vasculature( Scott et al., 2013 ). Because they replicate real biological cellular entities, hybrid automatons or agent based models can be used to model complex cell-microenvironmental interactions in a detailed mechanistic fashion in the context of metastasis( Pennisi et al., 2009 ; Wang et al., 2015 ). In addition to the biochemical signaling pathways, metastasis also involves interactions between cells in both the tissue of tumor origin, or in distal metastatic nodes. While a detailed systems understanding of the multiple steps involved in this process is lacking, there have been attempts at stochastic modeling of some of these steps at various levels of detail( In et al., 2017 ; Newton et al., 2012 ; Speer et al., 1984 ). While stochastic modeling may not completely describe the mechanism, it does provide an approach to generate hypotheses for metastatic site selection guided by clinical observations. Mechanistic models have been successful in describing biological phenomena where parameters are known, or can be optimally searched in a constrained manner, e.g. to model signaling motifs at subcellular levels, or using cellular automata showing interactions between a few cells. The objective is to integrate these sub-systems models to create a systems understanding of metastasis. However, such integration of sub-system models may not capture all the emergent behaviors at larger scales.
The field of systems biology could benefit from the introduction of model formalisms, the absence of which has constrained multi-scale integration of the various sub-system models. There have been attempts to formalize and describe biological interactions at different scales. Systems Biology Markup Language is a complex multi-paradigm XML-based standard for model description( Hucka et al., 2003 ). Multiple software packages use SBML or a subset of its capabilities for simulation, visualization, or editing systems biology models( Konig et al., 2012 ; Lopez et al., 2013 ). The Biomodels database has made more than 8000 SBML databases available for use by other researchers( Le Novere et al., 2006 ). While SBML is versatile and capable of representing models developed in many systems biology studies, emerging experimental knowledge is not necessarily used to continuously refine a complete and unified model covering all aspects of cancer invasion and growth. Integrative frameworks and platforms have recently been developed and adopted, including PySB( Lopez et al., 2013 ), and natural language processing based formalism to create automated assembly of signaling formalism from word descriptions( Gyori et al., 2017 ). The goal of a systems integration of the metastatic cascade would be served well if cancer biologists and systems biologists arrive towards a common formalism to describe interactions of molecules, or cells in the context of their localization and states.
The multi-scale perspective of cancer metastasis requires an appreciation that the phenotypes that manifest at one scale are likely informed by regulatory events at other scales. As an example, relevant to clinical applications, the genetic landscape of cancer determines epidemiology, while cellular and tissue level scales involving interaction of cancer cells with matrix and other cell types inform the histological outcomes. For example, technologies like direct tissue proteomics allow high resolution proteomics from paraffin-embedded microdissection biopsies. Using laser-ablated microbiopsies, this approach identified more than 400 prostate specific genes as well as distinct metabolic pathways which may contribute to progression of prostate cancer at different stages( Hwang et al., 2007 ). Moreover, laser capture micro-ablation, combined with single cell transcriptomics, or even flow cytometry, are able to connect a tumor’s architecture with its molecular scale( Joseph and Gnanapragasam, 2011 ). In another example of bridging across scales, mathematical modeling was used to present an eco-evolutionary perspective of metastasis, explaining how mutations could facilitate evolution of cancer cells to break tissue homeostasis, and in turn transform the tissue environment itself( Basanta and Anderson, 2017 ).
Statistical Network Models – going beyond single gene associations in cancer metastasis
Systems biology is often referred to as networks of networks, integrating the knowledge of various interacting species across different biological scales. The era of big data collection has moved beyond sequencing of the genome, or the transcriptome, and now extends to identification of large number of metabolites, proteins with post-translational modifications and high content information about their subcellular localization. Measurement of these multi-omics has prompted the use of more sophisticated bioinformatics techniques that go beyond estimating the importance of individual genes to understanding how networks of molecules cooperate to promote cancer metastasis. Network information provides a convenient format for researchers to incorporate previous biological knowledge to generate hypothesis. These networks can be genetic, signaling, or metabolic, and operate within a cell or between cells. Whole genome sequencing has facilitated attempts to identify causal genetics of metastasis, but its integration with gene regulatory networks can further elicit specific gene interactions mediating metastatic phenotypes( Leiserson et al., 2015 ),( Paull et al., 2013 ). The large number of passenger mutations in metastatic tumors, and relatively limited number of patient samples poses a challenge, but heuristics applied to interactome network can allow prioritization of genes for further investigation. Network approaches have been applied to protein interaction, regulatory, gene co-expression networks, as well as on mutation co-occurrence to provide systems molecular interaction snapshots of metastasis( Shin et al., 2017 ). In addition, systems network analysis can be used to generate falsifiable hypotheses linking disease to holistic systems properties, as has been shown for metastasis as a progression towards network entropy ( Teschendorff and Severini, 2010 ; West et al., 2012 ) .
Another level of complexity emerges from the multiple interdependent molecular snapshots of a metastatic cell: the transcriptomic state informs proteomic changes, which would then inform the metabolomics states of cells. Although techniques have emerged to get single cell snapshots in all these states, these snapshots are only partially predictive of phenotypes. As an example, highly resolved multiple drug treatment regimen and high density observations in cancer cells combined with computational modeling revealed that sequential administration of drugs re-wires signaling cascades leading to enhanced apoptosis( Lee et al., 2012 ; Miller et al., 2016 ). As the quality of interaction data improves and more sophisticated methods are devised, it should be possible to combine multiple types of interactions. For example, understanding how the signaling networks within migrating cells in metastasis integrate with the host cells using ligand receptor interactions can shed light on the functional impact of some driver mutations. Understanding the network of post-translational modifications in signaling in conjunction with the transcription factor-target regulatory interactions can help delineate the differences between the effect of mutations in protein coding regions, cis-regulatory regions, and changes in gene expression causing metastasis.
Different approaches in machine learning, e.g. learning data representations, or deep learning have also begun to derive useful inferences from experimental observations, which could serve to parametrize and scale current models of metastasis. Although deep learning has been used mostly in the fields of vision, architectures like recursive neural networks, or their variants, can be used for knowledge extraction since they are more attuned for sequential information often present in omics data( Min et al., 2017 ). Machine learning approaches are also well suited to glean insight from heterogeneous cell populations present in cancer microenvironment, which necessitate analysis of multiple modalities of experimental observations in high volume. For example, deep learning has been used to increase accuracy in the diagnosis of metastatic lesions from histological slides( Litjens et al., 2016 ; Wang et al., 2016 ) and fMRI images( Liu et al., 2017b ). Similarly, algorithms are being developed to reclassify cancer subtypes based on more detailed genotypic data which were previously based on histological analysis, presenting opportunities for more targeted therapy( Cancer Genome Atlas Research, 2014 ; Han et al., 2014 ). Although generally viewed as “black box” approaches unable to inform about disease mechanisms, other approaches provide avenues for interpretable neural network models( Michael et al., 2018 ; Samek et al., 2017 ). Other recent developments in deep learning methods have been applied in the analysis of complex systems of interacting components seen in various physical systems( Broecker et al., 2017 ; Schindler et al., 2017 ), and similar methods may be ripe for the analysis of the dynamics of cell populations in metastasis, beyond what can be modeled using biochemical pathways within cells. Recent theoretical development of deep learning models that operate on graph structured data( Defferrard et al., 2016 ; Kipf and Welling, 2016 ) has the potential to integrate protein and gene interaction network information to relate cancer related phenotypes with genotypes and expression data( Ma and Zhang, 2018 ; Rhee et al., 2017 ).
In the future, network analysis and machine learning approaches may be used to directly inform a mechanistic understanding of metastasis. Dcell uses deep neural networks to model the growth phenotype of gene deletion, while explaining the prediction in terms of a chain of causal changes in different modules such as subcellular structures and pathways( Ma et al., 2018 ). Such methods can be augmented to include systems of multiple cell types to address phenotypes relevant to metastasis. Innovative applications of network inference and machine learning could bridge the gap between large amounts of biological data and incomplete mechanistic models using concepts such as equation discovery( Dzeroski and Todorovski, 2008 ) and hybrid mechanistic-machine learning models( Hua et al., 2006 ). At a minimum, they will inform, and more likely prioritize, the molecular and biochemical components that are included in more traditional systems biology-based mechanistic models.
Experimental Models and Technologies to Facilitate Systems Study of Metastasis
Systems biology is often approached through a circular iterative process, where data collection informs computational modeling to generate testable hypotheses, and in turn, the outcome of the subsequent hypothesis testing refines the computational model. Required for these iterations are quantitative multivariate experimental approaches that adequately capture the complexity (or simplicity) of the system, and, in many cases, provide longitudinal data ( Table 1 , Figure 2 ). In the study of cancer metastasis, the most often utilized experimental systems range from single-cell measurement techniques that provide a snapshot of the molecular characteristics of metastatic cells to genetically modified mouse models (GEMMs) that facilitate the study of the entire metastatic process. Further, investigating the progression of cancer metastasis may require tailored approaches to understand the mechanistic underpinnings driving those processes ( Table 2 ). Some of the more recent developments regarding experimental systems to inform or test systems biology models are reviewed below along with a wish list for technology developers interested in contributing to this emerging area.
Single-cell approaches to studying cancer metastasis
The recent decreases in the cost and concomitant increases in the portability and flexibility of single-cell technology will facilitate a deeper understanding of tumor cell heterogeneity in metastasis( Bush et al., 2017 ; Gierahn et al., 2017 ). Particularly, single-cell DNA and RNA sequencing techniques are employed to investigate primary tumors, metastatic lesions, circulating tumor cells, and disseminated tumor cell singlets and clusters( Leung et al., 2017 ; Ting et al., 2014 ; Tirosh et al., 2016 ). A better understanding of the numerous molecular characteristics that give rise to metastatic cells will lead to better predictive models for patient treatment and outcome. However, when employing these approaches to parameterize or test the hypotheses derived from computational systems biology models, it is important to note that single-cell genomic and transcriptomic data pose analytical hurdles, including a low signal to noise ratio due to low read coverage and non-trivial normalization that currently makes it challenging to compare multiple datasets across patients or experimental conditions. Additionally, interrogation of small cell populations, such as dormant metastatic cells, may limit statistically meaningful insights if desired population comparisons are not carefully considered during experimental design. Considerable theoretical work has produced numerous useful data analysis techniques for single-cell genomics, transcriptomics, and proteomics, and the subsequent incorporation of these data into predictive computational models is now beginning( Liu et al., 2017a ; Marcotte et al., 2016 ; Setty et al., 2016 ; Tanay and Regev, 2017 ; Villani et al., 2017 ).
One challenge in interpreting tumor heterogeneity at the single-cell level is the biological role of “rare” cancer cells captured at a single time point. Such cells could be viewed either as an important minor subpopulation, forming the tail of a distribution representing a cancer cell signature, or as traversing through a dynamic cellular state. In the absence of a longitudinal sampling strategy, coupling information at the genomic or transcriptomic level with experimental measurements of cell phenotype may provide guidance to the level of granularity required when interpreting single time point data. Techniques that can accurately quantify, at the single cell level, a physical characteristic, such as a change in cell mass or modulation of cell motility due to drug treatment or an environmental perturbation, could provide the additional data required to differentiate between a stable and transient cell state when coupled with single-cell molecular data( Rojas-Puentes et al., 2016 ). Even when longitudinal data is available, the integration of multiple data types, such as bulk and single-cell whole-genome sequencing and transcriptomic profiling may be required to predict an outcome with accuracy( Brady et al., 2017 ). Finally, single-cell sequencing of metastatic lesions coupled with computational methods and lineage tracing of metastases in animal models amenable to imaging, such as C. elegans , or zebrafish, holds the potential to address outstanding questions about the origins and clonality of metastasis, as well as the emergence of new phenotypes such as drug resistance( Brown et al., 2017 ; Heilmann et al., 2015 ; Kyriakakis et al., 2015 ).
Whole-organism experimental systems for metastasis research
Genetically modified animal models of metastasis have been developed and successfully utilized to study all known steps within the metastatic cascade. The benefits and drawbacks of the most frequently utilized models have been thoroughly reviewed elsewhere( Gomez-Cuadrado et al., 2017 ; van Marion et al., 2016 ). Developments in gene editing have facilitated large-scale in vivo studies of the genetic alterations that drive cancer tumor growth and metastasis( Chen et al., 2015 ; Kalhor et al., 2018 ). Computational integration of these data with information regarding modulation of epigenetic state and alteration of the transcriptome could provide insight into disease mechanism.
The development of lineage tracing tools( Sikandar et al., 2017 ) could allow for straightforward parameterization or testing of systems biology models through visualization of the kinetics of metastasis or by quantitatively reporting on cell populations in distant metastatic sites of interest. High temporal resolution is on the wish list of many systems biologists who study metastasis, but is difficult to obtain in mammalian models except through the incorporation of imaging windows that facilitate multiple rounds of high resolution intravital imaging( Entenberg et al., 2017 ; Suijkerbuijk and van Rheenen, 2017 ). Rapid advancement in functional imaging of metabolic or signaling state of tissues in vivo could be used to contextualize metastatic steps with the tissue microenvironment ( Herzog et al., 2013 ; Knox et al., 2018 ; Miloushev et al., 2018 ; Shangguan et al., 2018 ). Zebrafish have emerged as an alternative system to study aspects of cancer metastasis at high temporal and spatial resolution ( Heilmann et al., 2015 ), allowing for quantification of cell-cell or cell-stroma interactions and relatively easy genetic manipulation. However, in the instances when it is desirable to directly study human cells, zebrafish offer a suboptimal immune microenvironment, similar to the many xenograft-derived in vivo mouse models currently in-use. Finally, it is worth noting that a popular drug screening tool, the patient derived xenograft (PDX) mouse model, has not yet found high utility within the cancer metastasis field. There are limited PDX systems that recapitulate metastases observed in human patients ( Jiang et al., 2015 ; Whittle et al., 2015 ). However, humanized mouse models combined with PDX provide avenues to study cancer metastasis in the context of the correct host immune system ( Jespersen et al., 2017 ; Rongvaux et al., 2017 ; Zheng et al., 2018 ).
Bioengineered in vitro models for studying metastasis
In vitro and ex vivo tumor models offer simplified systems that can be perturbed with relative ease, while also being able to incorporate some of the complexity of tumor microenvironments such as variations in mechanical properties, matrix chemistry, paracrine signals, and cell-cell interactions( Katt et al., 2016 ; Singh et al., 2018 ; Zanoni et al., 2016 ). Andrew Ewald’s group, for example, has utilized human breast cancer organoids grown in three dimensional culture, complemented by engineered mouse models, to show that extracellular matrix characteristics inform invasive behavior and demonstrated that Twist1 regulates Protein Kinase D1 (PKD1) expression to drive metastatic dissemination ( Shamir et al., 2016 ). Jan Lammerding has studied the role of mechanical stress during transendothelial migration of cancer cells using microfluidic cancer transmigration models incorporating tissue mechanics, biochemical properties, and cell-cell interactions ( Cao et al., 2016 ; Singh et al., 2018 ). A liver microphysiological system, in which all the major cell types in the liver microenvironment are cultured together, including liver-specific immune cells, is being employed by Alan Wells and colleagues to study hepatotoxicity of cancer drugs as well as metastasis and dormancy of breast cancer cells in human liver tissue( Wheeler et al., 2014 ).
Systemic Perturbation Approaches
With the increasing adoption of CRISPR/Cas9 technology to target the human genome, image-guided tissue isolation, sequencing, and informatics, related approaches have been developed to systematically identify genetic basis for the various steps involved in the metastatic cascade. These screens typically involve creating a library of starting cellular cohort with single, or multiple genetic manipulation in each cell, and selectively sorting the cells that successfully pass through a phenotypic filter, identifying the genes that are enriched in the selected cohort. Enrichment hits could be revalidated using the same filter, or in a more complex system. Experimental models have also been developed that combine library screens with a phenotypic filter such as cell motility or combine a phenotypic functionality, such as dissemination combined with subsequent bioinformatics analysis( Konen et al., 2017 ). CRISPR/Cas9 based screens are increasingly being utilized to create autochthonous models that facilitate investigation of the combinatorial genetic mutations that drive cancer metastasis ( Chow et al., 2017 ; Shen et al., 2017 ). Similarly, platforms investigating the role of extracellular matrix at different stages of metastases have been developed to explore non-cell autonomous processes. As an example, Claudia Fischbach’s group observed that the link between cancer malignancy and obesity could be partially attributed to increased collagen deposition by adipocyte stem cells in response to conditioned medium from tumor cells. These findings correlate with observations that adipose tissue in obese patients is stiffer, more collagenous, and may abet cancer metastasis by selective enrichment of cancer stem cell subpopulations( Chandler et al., 2012 ; Seo et al., 2015 ).
Precision medicine: deeper omics understanding in the clinical setting
In addition to informing both drug development and a causal understanding of metastasis, systems biology has also been instrumental in the development of patient specific causal analysis and treatment modality( Jia and Zhao, 2014 ). Techniques like patient specific xenografts allow the identification of targetable tumor specific antigens and the optimization of drug regimens( Karamboulas et al., 2018 ; Lange et al., 2018 ; Malaney et al., 2014 ). Patient and sample specific analysis is even more pertinent for cancer metastasis because the range of possible genetic, epigenetic, or transcriptomic variant combinations that may be causal for overcoming each obstacle from cancer initiation to proliferation, invasion, etc. may be more than the number of patient samples. Therefore, the classical approach of finding statistically significant differences between pathological and control samples is inadequate, with the number of parameters growing much larger than the number of samples. Single sample (N of 1) analysis methods seek to solve these problems in several ways. Classically, N of 1 studies relied on the collection of paired control-intervention data from the same individual by applying some temporal sequence of treatment and placebo/control. For cancer and metastasis, the comparison of matched samples of some combination of normal, primary tumor, and metastatic tumor has been used to find causal mutations and/or suitable interventions( Al-Ahmadie et al., 2014 ; Brannon and Sawyers, 2013 ; Kadakia et al., 2015 ). Califano et al. have developed a network analysis method to differentiate between causal and passenger mutations for individual patients based on the plausible set of causal genes that may be affecting the master regulators through a regulatory network( Chen et al., 2014 ). Identification of the pathologically important regulators allows the targeted drug screens on the patient derived xenografts to arrive at a treatment plan. We believe similar approaches that integrate the existing knowledge of cancer biology (via the construction of regulatory network), patient specific genotyping, and experimental techniques are an ideal application of systems biology in the service of patient care.
The development of less invasive tests, such as liquid biopsies for cancer biomarkers( Bettegowda et al., 2014 ) has opened an avenue for the wider application of precision medicine for pre-emptive surveillance for cancer initiation, metastatic growth( Li et al., 2010 ), chances of metastasis after treatment on the primary site, or for the selection of appropriate therapy. These biomarkers could be the expression of certain genes( Zheng et al., 2007 ), methylation patterns( Barault et al., 2018 ; Garrigou et al., 2016 ) or mutations( Board et al., 2010 ; Diehl et al., 2008 ) in circulating tumor DNA, the types of circulating tumor and immune cells( Ilie et al., 2012 ), and detected from blood or other material such as sputum, urine, or stool. The discovery and correct interpretation of these biomarkers is again dependent on the statistical issues regarding small sample size and larger number of parameters.
Integrating Models of Metastasis
Cancer metastasis is a multidimensional process, unfolding at many biological scales, including molecular signaling networks, protein-protein interactions, metabolism, cell-cell and cell-ECM interactions, organ-level control, disease manifestation and epidemiology. Our ability to describe events in each of those scales will need to be augmented to also inform events in other scales. Integrating the knowledge of all these snapshots at a single cell level would allow determination of consistently active motifs driving metastatic phenotypes. These biological scales can be practically useful as nodes of data integration, and positioning our understanding of the systemic nature of metastasis ( Figure 3 ). Integration of results across all scales may be very challenging, and so a piecemeal approach is warranted. Multi-scale modeling across scales defined by informatics, e.g. genomic, epigenomic, transcriptomic scales is now attempted by specialized next generation sequencing (NGS) techniques, including ChIP Seq (Chromatin Immunoprecipitation Sequencing), ATAC Seq (to access chromatin accessibility genome wide), PRO Seq (Precision nuclear run-on sequencing)( Meyer and Liu, 2014 ), and many other technologies. The objective of these technologies is essentially to systematically explore the mechanism of gene regulation resulting in a given transcriptomic output. Several attempts are now made to correlatively analyze the transcriptomic, proteomic, and even metabolomics scales systematically in a physiological system( Bahado-Singh et al., 2017 ; Garcia et al., 2012 ; Rabinowitz et al., 2017 ; Zhao et al., 2018 ). Such integrative approaches will be crucial in mechanistically understanding cancer metastasis as a multiscale disease ( Figure 3 ).
Integration of data across scales, both not characterized by “sequence information” is fraught with challenges that are more profound. Well characterized phenotypes with richly-defined feature sets could be mapped to transcriptomic, and genomic scales; e.g. characterizing tumor organoid shape and other characteristics for precision medicine, as well as RNA Sequencing ( Clark et al., 2018 ; Ewald, 2017 ). Tissue level details can be integrated with transcriptomics by spatial scRNA sequencing, for which more and more methods are being developed ( Moncada et al., 2019 ; Stahl et al., 2016 ). Similarly, signaling state of cells can be correlatively assessed with the transcriptomic state( Zhang et al., 2019 ), which is likely to be benefitted by single cell RNA sequencing correlated with parallel multiplexed imaging or cytometry. Intercellular communication between metastatic cancer cells and stromal cells, including the immune subpopulations, could be integratively explored by scRNA sequencing, simplistically by creating ligand-receptor interaction maps, and in a more detailed manner by combining parallel means of data collection, e.g. secretome analysis. These integrative methods aim towards validating and confirming the information flow from one physiological scales to another, however, more mechanistic integrative efforts are being made combining computational modeling of signals between cells constrained by defined boundaries in the context of a tissue( Ghaffarizadeh et al., 2018 ; Letort et al., 2019 ; Zangooei and Habibi, 2017 ).
Experimental in vitro or ex vivo models that faithfully recapitulate the entire process of metastasis are coming online with the advent of tissue-on-a-chip and organ-on-a-chip technologies ( Table 1 ). These systems are likely to offer a controlled environment to build and test computational models that describe the various sub-systems of the metastatic cascade. These types of multi-scale systems biology approaches will offer a way to test large numbers of hypotheses regarding development and treatment of metastatic disease before advancing to the infinitely complex in vivo environments. It is only through such systems-level understanding of cancer metastasis that we can hope to decrease the lethality of the disease and continue to develop detection and treatment strategies. A global and mechanistic model of metastasis with a predictive flow of information across larger scales is still a work in progress, and requires methods to formalize data collection across scales, techniques to validate derived changes at a scale informed by another scale, as well as systems approaches to understand progression of metastasis combining several spatio-temporal scales ( Figure 3 ).
Cancer metastasis has continued to confound researchers owing to its complex, and not completely determinable, pathological trajectory. The complexity in disease progression arises because essentially cancer is a disease of abnormal cell proliferation, and metastasis involves successfully encountering physiological hurdles, both aspects resulting in a strong evolutionary thrust defining the metastatic cascade. Cancer metastasis, is therefore an evolving disease and is a combined outcome of cells that metastasize, as well as a series of microenvironmental factors they interact with, collude, or surmount. Although, each instance of metastasis could be unique, the quest is to find commonalities which could be therapeutically targeted. The complexity of metastasis through its chronological progression, and its manifestation in various biological scales calls for a systems approach to mechanistically understand metastasis. This approach will involve integrating information gained across different scales, and mechanistically modeling disease progression as a functional outcome of the complex interaction between cancer and the ecology it interacts with. Important technical advancements in recent years to gain knowledge at a systems level at various biological scales have raised a hope that cancer metastasis may itself be modeled using a multiscale and systems approach. The need is to develop methods to integrate these approaches across scales, and stage of metastasis towards creating a systems mechanistic model of cancer metastasis.
Acknowledgements:
We would like to extend our sincere thanks to Dr. Shannon K. Hughes, National Cancer Institutes for providing crucial stewardship in envisaging, organizing, and executing the writing of this manuscript. This manuscript could not have been written without her support. We would also like to extend our gratitude to Dr. Daniel Gallahan, and Dr. Nancy Boudreau from the National Cancer Institutes for providing constructive criticisms in support in writing the manuscript. Funding for this work was provided by National Cancer Institute U54 Center Grant on Cancer Systems Biology 1U54CA209992.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
- Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al. (2014). Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158 , 1110–1122. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Aguado BA, Hartfield RM, Bushnell GG, Decker JT, Azarin SM, Nanavati D, Schipma MJ, Rao SS, Oakes RS, Zhang Y, et al. (2018). Biomaterial Scaffolds as Pre-metastatic Niche Mimics Systemically Alter the Primary Tumor and Tumor Microenvironment. Adv Healthc Mater 7 , e1700903. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Aguilar E, Marin de Mas I, Zodda E, Marin S, Morrish F, Selivanov V, Meca-Cortes O, Delowar H, Pons M, Izquierdo I, et al. (2016). Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program. Stem Cells 34 , 1163–1176. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ahmad FK, Deris S, and Othman NH (2012). The inference of breast cancer metastasis through gene regulatory networks. J Biomed Inform 45 , 350–362. [ PubMed ] [ Google Scholar ]
- Al-Ahmadie H, Iyer G, Hohl M, Asthana S, Inagaki A, Schultz N, Hanrahan AJ, Scott SN, Brannon AR, McDermott GC, et al. (2014). Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy. Cancer Discov 4 , 1014–1021. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Alexander S, Koehl GE, Hirschberg M, Geissler EK, and Friedl P (2008). Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model. Histochem Cell Biol 130 , 1147–1154. [ PubMed ] [ Google Scholar ]
- Bahado-Singh R, Poon LC, Yilmaz A, Syngelaki A, Turkoglu O, Kumar P, Kirma J, Allos M, Accurti V, Li J, et al. (2017). Integrated Proteomic and Metabolomic prediction of Term Preeclampsia. Sci Rep 7 , 16189. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TBK, Taunk NK, et al. (2018). Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553 , 467–472. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Barault L, Amatu A, Siravegna G, Ponzetti A, Moran S, Cassingena A, Mussolin B, Falcomata C, Binder AM, Cristiano C, et al. (2018). Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 67 , 1995–2005. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Basanta D, and Anderson ARA (2017). Homeostasis Back and Forth: An Ecoevolutionary Perspective of Cancer. Cold Spring Harb Perspect Med 7 . [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, and Lyden D (2016). Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. Cancer cell 30 , 836–848. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Becker SA, Feist AM, Mo ML, Hannum G, Palsson BO, and Herrgard MJ (2007). Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat Protoc 2 , 727–738. [ PubMed ] [ Google Scholar ]
- Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al. (2014). Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6 , 224ra224. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Blanco MA, LeRoy G, Khan Z, Aleckovic M, Zee BM, Garcia BA, and Kang Y (2012). Global secretome analysis identifies novel mediators of bone metastasis. Cell Res 22 , 1339–1355. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Blinov ML, Schaff JC, Vasilescu D, Moraru II, Bloom JE, and Loew LM (2017). Compartmental and Spatial Rule-Based Modeling with Virtual Cell. Biophys J 113 , 1365–1372. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Board RE, Wardley AM, Dixon JM, Armstrong AC, Howell S, Renshaw L, Donald E, Greystoke A, Ranson M, Hughes A, et al. (2010). Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer. Breast cancer research and treatment 120 , 461–467. [ PubMed ] [ Google Scholar ]
- Brady SW, McQuerry JA, Qiao Y, Piccolo SR, Shrestha G, Jenkins DF, Layer RM, Pedersen BS, Miller RH, Esch A, et al. (2017). Combating subclonal evolution of resistant cancer phenotypes. Nat Commun 8 , 1231. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Brannon AR, and Sawyers CL (2013). “N of 1” case reports in the era of whole-genome sequencing. The Journal of clinical investigation 123 , 4568–4570. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Broecker P, Carrasquilla J, Melko RG, and Trebst S (2017). Machine learning quantum phases of matter beyond the fermion sign problem. Sci Rep 7 , 8823. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Brown HK, Schiavone K, Tazzyman S, Heymann D, and Chico TJ (2017). Zebrafish xenograft models of cancer and metastasis for drug discovery. Expert Opin Drug Discov 12 , 379–389. [ PubMed ] [ Google Scholar ]
- Bush EC, Ray F, Alvarez MJ, Realubit R, Li H, Karan C, Califano A, and Sims PA (2017). PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens. Nat Commun 8 , 105. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Camacho DM, Collins KM, Powers RK, Costello JC, and Collins JJ (2018). Next-Generation Machine Learning for Biological Networks. Cell 173 , 1581–1592. [ PubMed ] [ Google Scholar ]
- Cancer Genome Atlas Research, N. (2014). Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513 , 202–209. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Cao X, Moeendarbary E, Isermann P, Davidson PM, Wang X, Chen MB, Burkart AK, Lammerding J, Kamm RD, and Shenoy VB (2016). A Chemomechanical Model for Nuclear Morphology and Stresses during Cell Transendothelial Migration. Biophys J 111 , 1541–1552. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Carcereri de Prati A, Butturini E, Rigo A, Oppici E, Rossin M, Boriero D, and Mariotto S (2017). Metastatic Breast Cancer Cells Enter Into Dormant State and Express Cancer Stem Cells Phenotype Under Chronic Hypoxia. Journal of cellular biochemistry . [ PubMed ]
- Carmona-Fontaine C, Deforet M, Akkari L, Thompson CB, Joyce JA, and Xavier JB (2017). Metabolic origins of spatial organization in the tumor microenvironment. Proceedings of the National Academy of Sciences of the United States of America 114 , 2934–2939. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ, Tims DT, Wang JX, Cheng L, Mohanan S, et al. (2012). Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proceedings of the National Academy of Sciences of the United States of America 109 , 9786–9791. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Chaturvedi P, Gilkes DM, Wong CC, Kshitiz, Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, et al. (2013). Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. The Journal of clinical investigation 123 , 189–205. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Chen H, Engkvist O, Wang Y, Olivecrona M, and Blaschke T (2018). The rise of deep learning in drug discovery. Drug Discov Today 23 , 1241–1250. [ PubMed ] [ Google Scholar ]
- Chen JC, Alvarez MJ, Talos F, Dhruv H, Rieckhof GE, Iyer A, Diefes KL, Aldape K, Berens M, Shen MM, et al. (2014). Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks. Cell 159 , 402–414. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Chen S, Sanjana NE, Zheng K, Shalem O, Lee K, Shi X, Scott DA, Song J, Pan JQ, Weissleder R, et al. (2015). Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160 , 1246–1260. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Cheung KJ, and Ewald AJ (2016). A collective route to metastasis: Seeding by tumor cell clusters. Science 352 , 167–169. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Cheung KJ, Gabrielson E, Werb Z, and Ewald AJ (2013). Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155 , 1639–1651. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS, et al. (2016). Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proceedings of the National Academy of Sciences of the United States of America 113 , E854–863. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Chow RD, Guzman CD, Wang G, Schmidt F, Youngblood MW, Ye L, Errami Y, Dong MB, Martinez MA, Zhang S, et al. (2017). AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nat Neurosci 20 , 1329–1341. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Clark AM, Kumar MP, Wheeler SE, Young CL, Venkataramanan R, Stolz DB, Griffith LG, Lauffenburger DA, and Wells A (2018). A Model of Dormant-Emergent Metastatic Breast Cancer Progression Enabling Exploration of Biomarker Signatures. Mol Cell Proteomics 17 , 619–630. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC, Phillips GM, et al. (2014). Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513 , 559–563. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et al. (2015). Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17 , 816–826. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Court CM, Ankeny JS, Hou S, Tseng HR, and Tomlinson JS (2015). Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis. Expert Rev Mol Diagn 15 , 1491–1504. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Defferrard M, Bresson X, and Vandergheynst P (2016). Convolutional neural networks on graphs with fast localized spectral filtering. Paper presented at: Advances in Neural Information Processing Systems .
- Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, et al. (2008). Circulating mutant DNA to assess tumor dynamics. Nat Med 14 , 985–990. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Dzeroski S, and Todorovski L (2008). Equation discovery for systems biology: finding the structure and dynamics of biological networks from time course data. Curr Opin Biotechnol 19 , 360–368. [ PubMed ] [ Google Scholar ]
- Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, et al. (2005). Multigene methylation analysis for detection and staging of prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 11 , 6582–6588. [ PubMed ] [ Google Scholar ]
- Entenberg D, Pastoriza JM, Oktay MH, Voiculescu S, Wang Y, Sosa MS, Aguirre-Ghiso J, and Condeelis J (2017). Time-lapsed, large-volume, high-resolution intravital imaging for tissue-wide analysis of single cell dynamics. Methods 128 , 65–77. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ewald AJ (2017). Pulling cells out of tumours. Nat Cell Biol 19 , 147–149. [ PubMed ] [ Google Scholar ]
- Fidler IJ (2003). The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3 , 453–458. [ PubMed ] [ Google Scholar ]
- Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al. (2015). Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527 , 472–476. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Fluegen G, Avivar-Valderas A, Wang Y, Padgen MR, Williams JK, Nobre AR, Calvo V, Cheung JF, Bravo-Cordero JJ, Entenberg D, et al. (2017). Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol 19 , 120–132. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Friedl P, and Gilmour D (2009). Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10 , 445–457. [ PubMed ] [ Google Scholar ]
- Friedman N, Linial M, Nachman I, and Pe’er D (2000). Using Bayesian networks to analyze expression data. J Comput Biol 7 , 601–620. [ PubMed ] [ Google Scholar ]
- Furukawa M, Wheeler S, Clark AM, and Wells A (2015). Lung epithelial cells induce both phenotype alteration and senescence in breast cancer cells. PloS one 10 , e0118060. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Garcia M, Millat-Carus R, Bertucci F, Finetti P, Birnbaum D, and Bidaut G (2012). Interactome-transcriptome integration for predicting distant metastasis in breast cancer. Bioinformatics 28 , 672–678. [ PubMed ] [ Google Scholar ]
- Garrigou S, Perkins G, Garlan F, Normand C, Didelot A, Le Corre D, Peyvandi S, Mulot C, Niarra R, Aucouturier P, et al. (2016). A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker. Clin Chem 62 , 1129–1139. [ PubMed ] [ Google Scholar ]
- Ghaffarizadeh A, Heiland R, Friedman SH, Mumenthaler SM, and Macklin P (2018). PhysiCell: An open source physics-based cell simulator for 3-D multicellular systems. PLoS Comput Biol 14 , e1005991. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY, et al. (2013). The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15 , 807–817. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Gierahn TM, Wadsworth MH 2nd, Hughes TK, Bryson BD, Butler A, Satija R, Fortune S, Love JC, and Shalek AK (2017). Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput. Nat Methods 14 , 395–398. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Giese A, Loo MA, Tran N, Haskett D, Coons SW, and Berens ME (1996). Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67 , 275–282. [ PubMed ] [ Google Scholar ]
- Giesen C, Wang HA, Schapiro D, Zivanovic N, Jacobs A, Hattendorf B, Schuffler PJ, Grolimund D, Buhmann JM, Brandt S, et al. (2014). Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods 11 , 417–422. [ PubMed ] [ Google Scholar ]
- Goldsmith SR, Fiala MA, Dukeman J, Ghobadi A, Stockerl-Goldstein K, Schroeder MA, Tomasson M, Wildes TM, and Vij R (2019). Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study Clin Lymphoma Myeloma Leuk. [ PubMed ] [ Google Scholar ]
- Gomez-Cuadrado L, Tracey N, Ma R, Qian B, and Brunton VG (2017). Mouse models of metastasis: progress and prospects. Dis Model Mech 10 , 1061–1074. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Gyori BM, Bachman JA, Subramanian K, Muhlich JL, Galescu L, and Sorger PK (2017). From word models to executable models of signaling networks using automated assembly. Mol Syst Biol 13 , 954. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Han L, Yuan Y, Zheng S, Yang Y, Li J, Edgerton ME, Diao L, Xu Y, Verhaak RGW, and Liang H (2014). The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. Nat Commun 5 , 3963. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Harney AS, Arwert EN, Entenberg D, Wang Y, Guo P, Qian BZ, Oktay MH, Pollard JW, Jones JG, and Condeelis JS (2015). Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA. Cancer Discov 5 , 932–943. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Harper KL, Sosa MS, Entenberg D, Hosseini H, Cheung JF, Nobre R, Avivar-Valderas A, Nagi C, Girnius N, Davis RJ, et al. (2016). Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature [ PMC free article ] [ PubMed ]
- Hatzikirou H, Basanta D, Simon M, Schaller K, and Deutsch A (2012). ‘Go or grow’: the key to the emergence of invasion in tumour progression? Math Med Biol 29 , 49–65. [ PubMed ] [ Google Scholar ]
- Heilmann S, Ratnakumar K, Langdon E, Kansler E, Kim I, Campbell NR, Perry E, McMahon A, Kaufman C, van Rooijen E, et al. (2015). A Quantitative System for Studying Metastasis Using Transparent Zebrafish. Cancer research 75 , 4272–4282. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Heinrich R, Neel BG, and Rapoport TA (2002). Mathematical models of protein kinase signal transduction. Mol Cell 9 , 957–970. [ PubMed ] [ Google Scholar ]
- Herrick DB, Lin B, Peterson J, Schnittke N, and Schwob JE (2017). Notch1 maintains dormancy of olfactory horizontal basal cells, a reserve neural stem cell. Proceedings of the National Academy of Sciences of the United States of America . [ PMC free article ] [ PubMed ]
- Herzog RI, Jiang L, Herman P, Zhao C, Sanganahalli BG, Mason GF, Hyder F, Rothman DL, Sherwin RS, and Behar KL (2013). Lactate preserves neuronal metabolism and function following antecedent recurrent hypoglycemia. The Journal of clinical investigation 123 , 1988–1998. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Hofschroer V, Koch KA, Ludwig FT, Friedl P, Oberleithner H, Stock C, and Schwab A (2017). Extracellular protonation modulates cell-cell interaction mechanics and tissue invasion in human melanoma cells. Sci Rep 7 , 42369. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, et al. (2015). Tumour exosome integrins determine organotropic metastasis. Nature 527 , 329–335. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Hua F, Hautaniemi S, Yokoo R, and Lauffenburger DA (2006). Integrated mechanistic and data-driven modelling for multivariate analysis of signalling pathways. J R Soc Interface 3 , 515–526. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A, et al. (2003). The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19 , 524–531. [ PubMed ] [ Google Scholar ]
- Hwang SI, Thumar J, Lundgren DH, Rezaul K, Mayya V, Wu L, Eng J, Wright ME, and Han DK (2007). Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues. Oncogene 26 , 65–76. [ PubMed ] [ Google Scholar ]
- Ibrahim-Hashim A, Robertson-Tessi M, Enriquez-Navas PM, Damaghi M, Balagurunathan Y, Wojtkowiak JW, Russell S, Yoonseok K, Lloyd MC, Bui MM, et al. (2017). Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution. Cancer Res 77 , 2242–2254. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ilie M, Hofman V, Ortholan C, Bonnetaud C, Coelle C, Mouroux J, and Hofman P (2012). Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer 118 , 1726–1737. [ PubMed ] [ Google Scholar ]
- Ilina O, Campanello L, Gritsenko PG, Vullings M, Wang C, Bult P, Losert W, and Friedl P (2018). Intravital microscopy of collective invasion plasticity in breast cancer. Dis Model Mech 11 . [ PMC free article ] [ PubMed ] [ Google Scholar ]
- In GK, Mason J, Lin S, Newton PK, Kuhn P, and Nieva J (2017). Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer. Convergent Science Physical Oncology 3 , 035002. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Jeon JS, Bersini S, Whisler JA, Chen MB, Dubini G, Charest JL, Moretti M, and Kamm RD (2014). Generation of 3D functional microvascular networks with human mesenchymal stem cells in microfluidic systems. Integr Biol (Camb) 6 , 555–563. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Jespersen H, Lindberg MF, Donia M, Soderberg EMV, Andersen R, Keller U, Ny L, Svane IM, Nilsson LM, and Nilsson JA (2017). Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model. Nat Commun 8 , 707. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Jia D, Jolly MK, Tripathi SC, Den Hollander P, Huang B, Lu M, Celiktas M, Ramirez-Pena E, Ben-Jacob E, Onuchic JN, et al. (2017). Distinguishing mechanisms underlying EMT tristability. Cancer Converg 1 , 2. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Jia P, and Zhao Z (2014). VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data. PLoS Comput Biol 10 , e1003460. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Jiang J, Wang DD, Yang M, Chen D, Pang L, Guo S, Cai J, Wery JP, Li L, Li HQ, et al. (2015). Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model. Oncotarget 6 , 15639–15651. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E, and Levine H (2016). Stability of the hybrid epithelial/mesenchymal phenotype. Oncotarget 7 , 27067–27084. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Joseph A, and Gnanapragasam VJ (2011). Laser-capture microdissection and transcriptional profiling in archival FFPE tissue in prostate cancer. Methods Mol Biol 755 , 291–300. [ PubMed ] [ Google Scholar ]
- Kadakia KC, Tomlins SA, Sanghvi SK, Cani AK, Omata K, Hovelson DH, Liu CJ, and Cooney KA (2015). Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment. J Hematol Oncol 8 , 109. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Kalhor R, Kalhor K, Mejia L, Leeper K, Graveline A, Mali P, and Church GM (2018). Developmental barcoding of whole mouse via homing CRISPR. Science . [ PMC free article ] [ PubMed ]
- Kalluri R (2016). The biology and function of fibroblasts in cancer. Nat Rev Cancer 16 , 582–598. [ PubMed ] [ Google Scholar ]
- Karamboulas C, Bruce JP, Hope AJ, Meens J, Huang SH, Erdmann N, Hyatt E, Pereira K, Goldstein DP, Weinreb I, et al. (2018). Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma. Cell Rep 25 , 1318–1331 e1314. [ PubMed ] [ Google Scholar ]
- Katt ME, Placone AL, Wong AD, Xu ZS, and Searson PC (2016). In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform. Front Bioeng Biotechnol 4 , 12. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Kipf TN, and Welling M (2016). Semi-supervised classification with graph convolutional networks. arXiv preprint arXiv :160902907.
- Kirouac DC, Du JY, Lahdenranta J, Overland R, Yarar D, Paragas V, Pace E, McDonagh CF, Nielsen UB, and Onsum MD (2013). Computational modeling of ERBB2-amplified breast cancer identifies combined ErbB2/3 blockade as superior to the combination of MEK and AKT inhibitors. Sci Signal 6 , ra68. [ PubMed ] [ Google Scholar ]
- Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, and Riethmuller G (1999). Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proceedings of the National Academy of Sciences of the United States of America 96 , 4494–4499. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Knox HJ, Kim TW, Zhu Z, and Chan J (2018). Photophysical Tuning of N-Oxide-Based Probes Enables Ratiometric Photoacoustic Imaging of Tumor Hypoxia. ACS Chem Biol 13 , 1838–1843. [ PubMed ] [ Google Scholar ]
- Kochanczyk M, Kocieniewski P, Kozlowska E, Jaruszewicz-Blonska J, Sparta B, Pargett M, Albeck JG, Hlavacek WS, and Lipniacki T (2017). Relaxation oscillations and hierarchy of feedbacks in MAPK signaling. Sci Rep 7 , 38244. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Konen J, Summerbell E, Dwivedi B, Galior K, Hou Y, Rusnak L, Chen A, Saltz J, Zhou W, Boise LH, et al. (2017). Image-guided genomics of phenotypically heterogeneous populations reveals vascular signalling during symbiotic collective cancer invasion. Nat Commun 8 , 15078. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Konig M, Drager A, and Holzhutter HG (2012). CySBML: a Cytoscape plugin for SBML. Bioinformatics 28 , 2402–2403. [ PubMed ] [ Google Scholar ]
- Korkut A, Wang W, Demir E, Aksoy BA, Jing X, Molinelli EJ, Babur O, Bemis DL, Onur Sumer S, Solit DB, et al. (2015). Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells. Elife 4 . [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Koush Y, de Graaf RA, Jiang L, Rothman DL, and Hyder F (2019). Functional MRS with J-edited lactate in human motor cortex at 4T. Neuroimage 184 , 101–108. [ PubMed ] [ Google Scholar ]
- Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H, Boettcher M, Mougiakakos D, Reichardt W, Bronsert P, et al. (2017). The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol 19 , 518–529. [ PubMed ] [ Google Scholar ]
- Kshitiz Gupta JA, Maziarz Jamie D., Hamidzadeh Archer, Liang Cong, Erkenbrack Eric M., Nam Hong, Haeger Jan-Dirk, Pfarrer Christiane, Hoang Thomas, Ott Troy, Spencer Thomas, Pavlicev Mihaela, Antczak Doug, Levchenko Andre, Wagner Gunter P. (2019). The Evolution of Placental Invasion and Cancer Metastasis are Causally Linked. bioXiv [ PMC free article ] [ PubMed ]
- Kyriakakis E, Markaki M, and Tavernarakis N (2015). Caenorhabditis elegans as a model for cancer research. Mol Cell Oncol 2 , e975027. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Lambert AW, Pattabiraman DR, and Weinberg RA (2017). Emerging Biological Principles of Metastasis. Cell 168 , 670–691. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Lange T, Oh-Hohenhorst SJ, Joosse SA, Pantel K, Hahn O, Gosau T, Dyshlovoy SA, Wellbrock J, Feldhaus S, Maar H, et al. (2018). Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer. Sci Rep 8 , 17535. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Le Novere N, Bornstein B, Broicher A, Courtot M, Donizelli M, Dharuri H, Li L, Sauro H, Schilstra M, Shapiro B, et al. (2006). BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems. Nucleic Acids Res 34 , D689–691. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Lee JW, Stone ML, Porrett PM, Thomas SK, Komar CA, Li JH, Delman D, Graham K, Gladney WL, Hua X, et al. (2019). Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature 567 , 249–252. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Lee MJ, Ye AS, Gardino AK, Heijink AM, Sorger PK, MacBeath G, and Yaffe MB (2012). Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 149 , 780–794. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Lehmann S, Te Boekhorst V, Odenthal J, Bianchi R, van Helvert S, Ikenberg K, Ilina O, Stoma S, Xandry J, Jiang L, et al. (2017). Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells. Curr Biol 27 , 392–400. [ PubMed ] [ Google Scholar ]
- Leiserson MD, Wu HT, Vandin F, and Raphael BJ (2015). CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer. Genome Biol 16 , 160. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Letort G, Montagud A, Stoll G, Heiland R, Barillot E, Macklin P, Zinovyev A, and Calzone L (2019). PhysiBoSS: a multi-scale agent-based modelling framework integrating physical dimension and cell signalling. Bioinformatics 35 , 1188–1196. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Leung ML, Davis A, Gao R, Casasent A, Wang Y, Sei E, Vilar E, Maru D, Kopetz S, and Navin NE (2017). Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer. Genome Res 27 , 1287–1299. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Li B, Liu W, Wang L, Li M, Wang J, Huang L, Huang P, and Yuan Y (2010). CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma. Ann Surg Oncol 17 , 1917–1926. [ PubMed ] [ Google Scholar ]
- Li L, Knutsdottir H, Hui K, Weiss MJ, He J, Philosophe B, Cameron AM, Wolfgang CL, Pawlik TM, Ghiaur G, et al. (2019). Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity. JCI Insight 4 . [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Li X, Jiang J, Zhao X, Zhao Y, Cao Q, Zhao Q, Han H, Wang J, Yu Z, Peng B, et al. (2016a). In-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins. Oncotarget 7 , 22031–22049. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Li Y, Li F, Jiang F, Lv X, Zhang R, Lu A, and Zhang G (2016b). A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints. Int J Mol Sci 17 . [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Liang Y, Wu H, Lei R, Chong RA, Wei Y, Lu X, Tagkopoulos I, Kung SY, Yang Q, Hu G, et al. (2012). Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis. The Journal of biological chemistry 287 , 33533–33544. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Linde N, Casanova-Acebes M, Sosa MS, Mortha A, Rahman A, Farias E, Harper K, Tardio E, Reyes Torres I, Jones J, et al. (2018). Macrophages orchestrate breast cancer early dissemination and metastasis. Nat Commun 9 , 21. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Litjens G, Sanchez CI, Timofeeva N, Hermsen M, Nagtegaal I, Kovacs I, Hulsbergen-van de Kaa C, Bult P, van Ginneken B, and van der Laak J (2016). Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis. Sci Rep 6 , 26286. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Liu TY, Huang HH, Wheeler D, Xu Y, Wells JA, Song YS, and Wiita AP (2017a). Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics. Cell Syst 4 , 636–644 e639. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Liu Y, Stojadinovic S, Hrycushko B, Wardak Z, Lau S, Lu W, Yan Y, Jiang SB, Zhen X, Timmerman R, et al. (2017b). A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery. PloS one 12 , e0185844. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Lopez CF, Muhlich JL, Bachman JA, and Sorger PK (2013). Programming biological models in Python using PySB. Mol Syst Biol 9 , 646. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Lu J, Zeng H, Liang Z, Chen L, Zhang L, Zhang H, Liu H, Jiang H, Shen B, Huang M, et al. (2015). Network modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets. Sci Rep 5 , 14739. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ma J, Yu MK, Fong S, Ono K, Sage E, Demchak B, Sharan R, and Ideker T (2018). Using deep learning to model the hierarchical structure and function of a cell. Nat Methods 15 , 290–298. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ma T, and Zhang A (2018). AffinityNet: semi-supervised few-shot learning for disease type prediction. arXiv preprint arXiv :180508905.
- Malaney P, Nicosia SV, and Dave V (2014). One mouse, one patient paradigm: New avatars of personalized cancer therapy. Cancer Lett 344 , 1–12. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, and Massague J (2016). Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell 165 , 45–60. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Marcotte R, Sayad A, Brown KR, Sanchez-Garcia F, Reimand J, Haider M, Virtanen C, Bradner JE, Bader GD, Mills GB, et al. (2016). Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance. Cell 164 , 293–309. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Marlow R, and Dontu G (2015). Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures. Methods Mol Biol 1293 , 213–220. [ PubMed ] [ Google Scholar ]
- Massague J, and Obenauf AC (2016). Metastatic colonization by circulating tumour cells. Nature 529 , 298–306. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- McGillivray A, Golden NA, and Kaushal D (2015). The Mycobacterium tuberculosis Clp gene regulator is required for in vitro reactivation from hypoxia-induced dormancy. The Journal of biological chemistry 290 , 2351–2367. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Meyer CA, and Liu XS (2014). Identifying and mitigating bias in next-generation sequencing methods for chromatin biology. Nat Rev Genet 15 , 709–721. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Michael KY, Ma J, Fisher J, Kreisberg JF, Raphael BJ, and Ideker T (2018). Visible Machine Learning for Biomedicine. Cell 173 , 1562–1565. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Milanovic M, Fan DNY, Belenki D, Dabritz JHM, Zhao Z, Yu Y, Dorr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, et al. (2018). Senescence-associated reprogramming promotes cancer stemness. Nature 553 , 96–100. [ PubMed ] [ Google Scholar ]
- Miller MA, Oudin MJ, Sullivan RJ, Wang SJ, Meyer AS, Im H, Frederick DT, Tadros J, Griffith LG, Lee H, et al. (2016). Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance. Cancer Discov 6 , 382–399. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Miloushev VZ, Granlund KL, Boltyanskiy R, Lyashchenko SK, DeAngelis LM, Mellinghoff IK, Brennan CW, Tabar V, Yang TJ, Holodny AI, et al. (2018). Metabolic Imaging of the Human Brain with Hyperpolarized (13)C Pyruvate Demonstrates (13)C Lactate Production in Brain Tumor Patients. Cancer Res 78 , 3755–3760. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Min S, Lee B, and Yoon S (2017). Deep learning in bioinformatics. Brief Bioinform 18 , 851–869. [ PubMed ] [ Google Scholar ]
- Moncada R, Wagner F, Chiodin M, Devlin JC, Baron M, Hajdu CH, Simeone DM, and Yanai I (2019). Building a tumor atlas: integrating single-cell RNA-Seq data with spatial transcriptomics in pancreatic ductal adenocarcinoma bioRxiv
- Morales M, Arenas EJ, Urosevic J, Guiu M, Fernandez E, Planet E, Fenwick RB, Fernandez-Ruiz S, Salvatella X, Reverter D, et al. (2014). RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation. EMBO Mol Med 6 , 865–881. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Muzumdar MD, Dorans KJ, Chung KM, Robbins R, Tammela T, Gocheva V, Li CM, and Jacks T (2016). Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers. Nat Commun 7 , 12685. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, et al. (2007). Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450 , 1235–1239. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Neelakantan D, Zhou H, Oliphant MUJ, Zhang X, Simon LM, Henke DM, Shaw CA, Wu MF, Hilsenbeck SG, White LD, et al. (2017). EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells. Nat Commun 8 , 15773. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Newton PK, Mason J, Bethel K, Bazhenova LA, Nieva J, and Kuhn P (2012). A stochastic Markov chain model to describe lung cancer growth and metastasis. PloS one 7 , e34637. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Nguyen LK, Cavadas MA, Scholz CC, Fitzpatrick SF, Bruning U, Cummins EP, Tambuwala MM, Manresa MC, Kholodenko BN, Taylor CT, et al. (2013). A dynamic model of the hypoxia-inducible factor 1alpha (HIF-1alpha) network. J Cell Sci 126 , 1454–1463. [ PubMed ] [ Google Scholar ]
- Olivenca DV, Uliyakina I, Fonseca LL, Amaral MD, Voit EO, and Pinto FR (2018). A Mathematical Model of the Phosphoinositide Pathway. Sci Rep 8 , 3904. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Pal D, Heidenreich O, and Vormoor J (2016). Dormancy Stems the Tide of Chemotherapy. Cancer cell 30 , 825–826. [ PubMed ] [ Google Scholar ]
- Park J, Holmes WR, Lee SH, Kim HN, Kim DH, Kwak MK, Wang CJ, Edelstein-Keshet L, and Levchenko A (2017). Mechanochemical feedback underlies coexistence of qualitatively distinct cell polarity patterns within diverse cell populations. Proceedings of the National Academy of Sciences of the United States of America 114 , E5750–E5759. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Paull EO, Carlin DE, Niepel M, Sorger PK, Haussler D, and Stuart JM (2013). Discovering causal pathways linking genomic events to transcriptional states using Tied Diffusion Through Interacting Events (TieDIE). Bioinformatics 29 , 2757–2764. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Pennisi M, Cavalieri S, Motta S, and Pappalardo F (2016). A methodological approach for using high-level Petri Nets to model the immune system response. BMC Bioinformatics 17 , 498. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Pennisi M, Pappalardo F, and Motta S (2009). Agent based modeling of lung metastasis-immune system competition. Paper presented at: International Conference on Artificial Immune Systems (Springer). [ Google Scholar ]
- Persi E, Duran-Frigola M, Damaghi M, Roush WR, Aloy P, Cleveland JL, Gillies RJ, and Ruppin E (2018). Systems analysis of intracellular pH vulnerabilities for cancer therapy. Nat Commun 9 , 2997. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Poleszczuk J, Hahnfeldt P, and Enderling H (2015). Evolution and phenotypic selection of cancer stem cells. PLoS Comput Biol 11 , e1004025. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, Pecot CV, Kim SJ, Choi HJ, Bischoff FZ, et al. (2014). Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer cell 26 , 77–91. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Qutaish MQ, Zhou Z, Prabhu D, Liu Y, Busso MR, Izadnegahdar D, Gargesha M, Lu H, Lu ZR, and Wilson DL (2018). Cryo-Imaging and Software Platform for Analysis of Molecular MR Imaging of Micrometastases. Int J Biomed Imaging 2018 , 9780349. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Rabinowitz JS, Robitaille AM, Wang Y, Ray CA, Thummel R, Gu H, Djukovic D, Raftery D, Berndt JD, and Moon RT (2017 ). Transcriptomic, proteomic, and metabolomic landscape of positional memory in the caudal fin of zebrafish. Proceedings of the National Academy of Sciences of the United States of America 114 , E717–E726. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Rhee S, Seo S, and Kim S (2017). Hybrid approach of relation network and localized graph convolutional filtering for breast cancer subtype classification. arXiv preprint arXiv :171105859.
- Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, et al. (2012). EMT and dissemination precede pancreatic tumor formation. Cell 148 , 349–361. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Robertson-Tessi M, Gillies RJ, Gatenby RA, and Anderson AR (2015). Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. Cancer Res 75 , 1567–1579. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Robinson DR, Wu YM, Lonigro RJ, Vats P, Cobain E, Everett J, Cao X, Rabban E, Kumar-Sinha C, Raymond V, et al. (2017). Integrative clinical genomics of metastatic cancer. Nature 548 , 297–303. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Rojas-Puentes L, Cardona AF, Carranza H, Vargas C, Jaramillo LF, Zea D, Cetina L, Wills B, Ruiz-Garcia E, and Arrieta O (2016). Epithelial-mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy. Cancer Med 5 , 1989–1999. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ronaldson-Bouchard K, and Vunjak-Novakovic G (2018). Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development. Cell Stem Cell 22 , 310–324. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Rongvaux A, Willinger T, Martinek J, Strowig T, Gearty SV, Teichmann LL, Saito Y, Marches F, Halene S, Palucka AK, et al. (2017). Corrigendum: Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol 35 , 1211. [ PubMed ] [ Google Scholar ]
- Roy D, Steyer GJ, Gargesha M, Stone ME, and Wilson DL (2009). 3D cryo-imaging: a very high-resolution view of the whole mouse. Anat Rec (Hoboken) 292 , 342–351. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ryu H, Chung M, Dobrzynski M, Fey D, Blum Y, Lee SS, Peter M, Kholodenko BN, Jeon NL, and Pertz O (2015). Frequency modulation of ERK activation dynamics rewires cell fate. Mol Syst Biol 11 , 838. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Saengwimol D, Rojanaporn D, Chaitankar V, Chittavanich P, Aroonroch R, Boontawon T, Thammachote W, Jinawath N, Hongeng S, and Kaewkhaw R (2018). A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma. Sci Rep 8 , 15664. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Samek W, Wiegand T, and Müller K-R (2017). Explainable artificial intelligence: Understanding, visualizing and interpreting deep learning models. arXiv preprint arXiv :170808296.
- Schardt JA, Meyer M, Hartmann CH, Schubert F, Schmidt-Kittler O, Fuhrmann C, Polzer B, Petronio M, Eils R, and Klein CA (2005). Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer cell 8 , 227–239. [ PubMed ] [ Google Scholar ]
- Schillaci O, Fontana S, Monteleone F, Taverna S, Di Bella MA, Di Vizio D, and Alessandro R (2017). Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity. Sci Rep 7 , 4711. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Schindler F, Regnault N, and Neupert T (2017). Probing many-body localization with neural networks. Physical Review B 95 , 245134 [ Google Scholar ]
- Schubert OT, Ludwig C, Kogadeeva M, Zimmermann M, Rosenberger G, Gengenbacher M, Gillet LC, Collins BC, Rost HL, Kaufmann SH, et al. (2015). Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis. Cell host & microbe 18 , 96–108. [ PubMed ] [ Google Scholar ]
- Scott JG, Basanta D, Anderson AR, and Gerlee P (2013). A mathematical model of tumour self-seeding reveals secondary metastatic deposits as drivers of primary tumour growth. J R Soc Interface 10 . [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Seidel HS, and Kimble J (2011). The oogenic germline starvation response in C. elegans. PloS one 6 , e28074. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Senft D, and Ronai ZE (2016). Adaptive Stress Responses During Tumor Metastasis and Dormancy. Trends in cancer 2 , 429–442. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Seo BR, Bhardwaj P, Choi S, Gonzalez J, Andresen Eguiluz RC, Wang K, Mohanan S, Morris PG, Du B, Zhou XK, et al. (2015). Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci Transl Med 7 , 301ra130. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Setty M, Tadmor MD, Reich-Zeliger S, Angel O, Salame TM, Kathail P, Choi K, Bendall S, Friedman N, and Pe’er D (2016). Wishbone identifies bifurcating developmental trajectories from single-cell data. Nat Biotechnol 34 , 637–645. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Shamir ER, Coutinho K, Georgess D, Auer M, and Ewald AJ (2016). Twist1-positive epithelial cells retain adhesive and proliferative capacity throughout dissemination. Biol Open 5 , 1216–1228. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Shangguan C, Gan G, Zhang J, Wu J, Miao Y, Zhang M, Li B, and Mi J (2018). Cancer-associated fibroblasts enhance tumor (18)F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT. Theranostics 8 , 1376–1388. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Shen JP, Zhao D, Sasik R, Luebeck J, Birmingham A, Bojorquez-Gomez A, Licon K, Klepper K, Pekin D, Beckett AN, et al. (2017). Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. Nat Methods 14 , 573–576. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Shin D, Lee J, Gong JR, and Cho KH (2017). Percolation transition of cooperative mutational effects in colorectal tumorigenesis. Nat Commun 8 , 1270. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Shirure VS, Bi Y, Curtis MB, Lezia A, Goedegebuure MM, Goedegebuure SP, Aft R, Fields RC, and George SC (2018). Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. Lab Chip 18 , 3687–3702. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Sikandar SS, Kuo AH, Kalisky T, Cai S, Zabala M, Hsieh RW, Lobo NA, Scheeren FA, Sim S, Qian D, et al. (2017). Role of epithelial to mesenchymal transition associated genes in mammary gland regeneration and breast tumorigenesis. Nat Commun 8 , 1669. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Singh A, Brito I, and Lammerding J (2018). Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance. Trends in cancer 4 , 281–291. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Sosa MS, Bragado P, Debnath J, and Aguirre-Ghiso JA (2013). Regulation of tumor cell dormancy by tissue microenvironments and autophagy. Advances in experimental medicine and biology 734 , 73–89. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Speer JF, Petrosky VE, Retsky MW, and Wardwell RH (1984). A stochastic numerical model of breast cancer growth that simulates clinical data. Cancer Res 44 , 4124–4130. [ PubMed ] [ Google Scholar ]
- Spill F, Reynolds DS, Kamm RD, and Zaman MH (2016). Impact of the physical microenvironment on tumor progression and metastasis. Curr Opin Biotechnol 40 , 41–48. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Stahl PL, Salmen F, Vickovic S, Lundmark A, Navarro JF, Magnusson J, Giacomello S, Asp M, Westholm JO, Huss M, et al. (2016). Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science 353 , 78–82. [ PubMed ] [ Google Scholar ]
- Steinway SN, Zanudo JG, Ding W, Rountree CB, Feith DJ, Loughran TP Jr., and Albert R (2014). Network modeling of TGFbeta signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. Cancer research 74 , 5963–5977. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Suijkerbuijk SJE, and van Rheenen J (2017). From good to bad: Intravital imaging of the hijack of physiological processes by cancer cells. Dev Biol 428 , 328–337. [ PubMed ] [ Google Scholar ]
- Tanay A, and Regev A (2017). Scaling single-cell genomics from phenomenology to mechanism. Nature 541 , 331–338. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Tape CJ (2016). Systems Biology Analysis of Heterocellular Signaling. Trends Biotechnol 34 , 627–637. [ PubMed ] [ Google Scholar ]
- Tape CJ, Ling S, Dimitriadi M, McMahon KM, Worboys JD, Leong HS, Norrie IC, Miller CJ, Poulogiannis G, Lauffenburger DA, et al. (2016). Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation. Cell 165 , 910–920. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Taylor DP, Wells JZ, Savol A, Chennubhotla C, and Wells A (2013). Modeling boundary conditions for balanced proliferation in metastatic latency. Clinical cancer research : an official journal of the American Association for Cancer Research 19 , 1063–1070. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Te Boekhorst V, and Friedl P (2016). Plasticity of Cancer Cell Invasion-Mechanisms and Implications for Therapy. Adv Cancer Res 132 , 209–264. [ PubMed ] [ Google Scholar ]
- Teschendorff AE, and Severini S (2010). Increased entropy of signal transduction in the cancer metastasis phenotype. BMC Syst Biol 4 , 104. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ting DT, Wittner BS, Ligorio M, Vincent Jordan N, Shah AM, Miyamoto DT, Aceto N, Bersani F, Brannigan BW, Xega K, et al. (2014). Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep 8 , 1905–1918. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Tirosh I, Izar B, Prakadan SM, Wadsworth MH 2nd, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G, et al. (2016). Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352 , 189–196. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, et al. (2009). MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49 , 1571–1582. [ PubMed ] [ Google Scholar ]
- Uhl CG, Muzykantov VR, and Liu Y (2018). Biomimetic microfluidic platform for the quantification of transient endothelial monolayer permeability and therapeutic transport under mimicked cancerous conditions. Biomicrofluidics 12 , 014101. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, Poortmans P, Strobbe LJA, and Siesling S (2016). 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol 17 , 1158–1170. [ PubMed ] [ Google Scholar ]
- van Marion DM, Domanska UM, Timmer-Bosscha H, and Walenkamp AM (2016). Studying cancer metastasis: Existing models, challenges and future perspectives. Crit Rev Oncol Hematol 97 , 107–117. [ PubMed ] [ Google Scholar ]
- Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, and Nieto MA (2004). Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 18 , 1131–1143. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Vennin C, Herrmann D, Lucas MC, and Timpson P (2016). Intravital imaging reveals new ancillary mechanisms co-opted by cancer cells to drive tumor progression. F1000Res 5 . [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, Griesbeck M, Butler A, Zheng S, Lazo S, et al. (2017). Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356 . [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Waclaw B, Bozic I, Pittman ME, Hruban RH, Vogelstein B, and Nowak MA (2015). A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature 525 , 261–264. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Walsh LA, Alvarez MJ, Sabio EY, Reyngold M, Makarov V, Mukherjee S, Lee KW, Desrichard A, Turcan S, Dalin MG, et al. (2017). An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis. Cell Rep 20 , 1623–1640. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, et al. (2017). Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer. Breast cancer research and treatment 161 , 83–94. [ PubMed ] [ Google Scholar ]
- Wang D, Khosla A, Gargeya R, Irshad H, and Beck AH (2016). Deep learning for identifying metastatic breast cancer. arXiv 1606 05718. [ Google Scholar ]
- Wang Z, Butner JD, Kerketta R, Cristini V, and Deisboeck TS (2015). Simulating cancer growth with multiscale agent-based modeling. Semin Cancer Biol 30 , 70–78. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Wells A, Griffith L, Wells JZ, and Taylor DP (2013). The dormancy dilemma: quiescence versus balanced proliferation. Cancer Res 73 , 3811–3816. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- West J, Bianconi G, Severini S, and Teschendorff AE (2012). Differential network entropy reveals cancer system hallmarks. Sci Rep 2 , 802. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Wheeler SE, Clark AM, Taylor DP, Young CL, Pillai VC, Stolz DB, Venkataramanan R, Lauffenburger D, Griffith L, and Wells A (2014). Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system. Br J Cancer 111 , 2342–2350. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Whittle JR, Lewis MT, Lindeman GJ, and Visvader JE (2015). Patient-derived xenograft models of breast cancer and their predictive power. Breast Cancer Res 17 , 17. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, and Friedl P (2007). Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 9 , 893–904. [ PubMed ] [ Google Scholar ]
- Wu HQ, Cheng ML, Lai JM, Wu HH, Chen MC, Liu WH, Wu WH, Chang PM, Huang CF, Tsou AP, et al. (2017). Flux balance analysis predicts Warburg-like effects of mouse hepatocyte deficient in miR-122a. PLoS Comput Biol 13 , e1005618. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Xue Q, Lu Y, Eisele MR, Sulistijo ES, Khan N, Fan R, and Miller-Jensen K (2015). Analysis of single-cell cytokine secretion reveals a role for paracrine signaling in coordinating macrophage responses to TLR4 stimulation. Sci Signal 8 , ra59. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Ye X, Tam WL, Shibue T, Kaygusuz Y, Reinhardt F, Ng Eaton E, and Weinberg RA (2015). Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 525 , 256–260. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al. (2013). Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339 , 580–584. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Zangooei MH, and Habibi J (2017). Hybrid multiscale modeling and prediction of cancer cell behavior. PloS one 12 , e0183810. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A, and Tesei A (2016). 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep 6 , 19103. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Zervantonakis IK, Hughes-Alford SK, Charest JL, Condeelis JS, Gertler FB, and Kamm RD (2012). Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proceedings of the National Academy of Sciences of the United States of America 109 , 13515–13520. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C, et al. (2015). Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527 , 100–104. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Zhang Y, He W, and Zhang S (2019). Seeking for Correlative Genes and Signaling Pathways With Bone Metastasis From Breast Cancer by Integrated Analysis. Front Oncol 9 , 138. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Zhao P, Li J, Yang L, Li Y, Tian Y, and Li S (2018). Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease. Mol Med Rep 17 , 5247–5257. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Zheng B, Ren T, Huang Y, Sun K, Wang S, Bao X, Liu K, and Guo W (2018). PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse. J Hematol Oncol 11 , 16. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, and Kalluri R (2015). Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527 , 525–530. [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Zheng Z, Chen T, Li X, Haura E, Sharma A, and Bepler G (2007). DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med 356 , 800–808. [ PubMed ] [ Google Scholar ]
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
- View all journals
- Explore content
- About the journal
- Publish with us
- Sign up for alerts
- Published: 22 July 2024
The impact of sex on metastasis
- Yingsheng Zhang 1 &
- Xue Li ORCID: orcid.org/0000-0002-3072-0573 1
Nature Reviews Cancer ( 2024 ) Cite this article
232 Accesses
1 Altmetric
Metrics details
Sex matters in metastasis, but it has received little attention in research. Here, we highlight the emerging and important roles of biological sex in metastasis and advocate for mechanistic and quantitative studies for the future development of sex-tailored therapies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
195,33 € per year
only 16,28 € per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![metastasis research](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41568-024-00725-3/MediaObjects/41568_2024_725_Fig1_HTML.png)
Wang, Y. et al. Sex disparities in the clinical characteristics, synchronous distant metastasis occurrence and prognosis: a pan-cancer analysis. J. Cancer 12 , 498–507 (2021).
Article PubMed PubMed Central Google Scholar
Kaneko, S. & Li, X. X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism. Sci. Adv. https://doi.org/10.1126/sciadv.aar5598 (2018).
Liu, Q. et al. Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation. Nat. Commun. 15 , 1148 (2024).
Article CAS PubMed PubMed Central Google Scholar
Kong, N. et al. Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer. Proc. Natl Acad. Sci. USA 119 , e2112696119 (2022).
Li, J. et al. Histone demethylase KDM5D upregulation drives sex differences in colon cancer. Nature 619 , 632–639 (2023).
Kwon, H. et al. Androgen conspires with the CD8 + T cell exhaustion program and contributes to sex bias in cancer. Sci. Immunol. 7 , 2630 (2022).
Article Google Scholar
Tang, J. J. et al. Androgens drive sexual dimorphism in liver metastasis by promoting hepatic accumulation of neutrophils. Cell Rep. 39 , 110987 (2022).
Article CAS PubMed Google Scholar
Hermann, C. D. et al. TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer. J. Exp. Med. 218 , e20210911 (2021).
Ishikawa, K. et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320 , 661–664 (2008).
Fu, A. et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell 185 , 1356–1372.e26 (2022).
Pace, F. & Watnick, P. I. The interplay of sex steroids, the immune response, and the intestinal microbiota. Trends Microbiol. 29 , 849–859 (2021).
Rosiello, G. et al. Sex- and age-related differences in the distribution of bladder cancer metastases. Jpn. J. Clin. Oncol. 51 , 976–983 (2021).
Article PubMed Google Scholar
Download references
Acknowledgements
This work is supported by NIH/NCI, USA (P01CA278732-01 and R01CA267108-01A1).
Author information
Authors and affiliations.
Departments of Medicine and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Yingsheng Zhang & Xue Li
You can also search for this author in PubMed Google Scholar
Corresponding author
Correspondence to Xue Li .
Ethics declarations
Competing interests.
The authors declare no competing interests.
Rights and permissions
Reprints and permissions
About this article
Cite this article.
Zhang, Y., Li, X. The impact of sex on metastasis. Nat Rev Cancer (2024). https://doi.org/10.1038/s41568-024-00725-3
Download citation
Published : 22 July 2024
DOI : https://doi.org/10.1038/s41568-024-00725-3
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Quick links
- Explore articles by subject
- Guide to authors
- Editorial policies
Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.
![metastasis research metastasis research](https://verify.nature.com/verify/nature.png)
![](//serviteca.online/777/templates/cheerup2/res/banner1.gif)
IMAGES
VIDEO
COMMENTS
Your donation will support our mission to facilitate progressive research on processes fundamental to metastasis worldwide. 20th Biennial Congress of the MRS, London, United Kingdom, 2024. 19th Biennial Congress of the MRS, Buenos Aires, Argentina, 2022. 17th Biennial Congress of the MRS, Chengdu, China, 2016. Tell us your stories and we'll ...
The Metastasis Research Network (MetNet) supports collaborative, multidisciplinary projects that focus on several themes of the metastatic process and utilize integrative systems-level approaches. MetNet is advancing the understanding of metastasis as a non-linear, dynamic, and emergent process, as well as revealing mechanistic insights of ...
Metastasis is the hallmark of cancer that is responsible for the greatest number of cancer-related deaths. Yet, it remains poorly understood. The continuous evolution of cancer biology research ...
The Mission of the Metastasis Research Society (MRS): Our mission is to support progressive research on processes fundamental to metastasis. This includes supporting the exchange of information between researchers, clinicians, industry, and patients globally. We also strive to educate the public about metastatic cancer and raise awareness about ...
Metastasis is the spread of cancer to a part of the body distant from the original primary cancer. This occurs through the transfer of malignant or cancerous cells via lymph or blood. The new ...
Methods 14, 195-200 (2017). Quinn, J. J. et al. Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts. Science 371, eabc1944 (2021). This study of ...
Cancer metastasis is responsible for the vast majority of cancer‐related deaths worldwide. In contrast to numerous discoveries that reveal the detailed mechanisms leading to the formation of the primary tumor, the biological underpinnings of the metastatic disease remain poorly understood. Cancer metastasis is a complex process in which ...
At a recent NCI conference, survivors and researchers came together to discuss how to better address the needs of those living with metastatic cancer. Engineered immune cells deliver anticancer signal, prevent cancer from spreading. Posted: March 24, 2021. In an NCI study, treating mice with engineered immune cells shrank tumors and prevented ...
Clinical & Experimental Metastasis is an international, multidisciplinary journal devoted to the rapid publication of fundamental advances in basic and applied metastasis research. Official journal of the Metastasis Research Society. Provides a dynamic forum for molecular biology, pharmacology, tumor biology, and clinical cancer treatment.
Research autopsies: an abundant resource to study human metastasis Successfully dissecting and targeting the mechanisms that drive metastasis will depend on (1) a foundational understanding of metastasis mechanisms in patients, as well as (2) our ability to model metastasis in the laboratory.
Metastasis is the most lethal manifestation of cancer, but our understanding of its biology and how to effectively treat it is rapidly advancing. This review highlights established and emerging principles of metastasis and provides a framework to develop more effective therapies for metastatic cancer. ... Guidelines and definitions for research ...
Basic research supported by the Tumor Metastasis branch seeks to define the intrinsic and extrinsic mechanisms that allow tumor cells to leave the primary tumor, invade surrounding tissue, travel through the circulation or lymph, and enter, survive and colonize distant organs. Metastasis research encompasses both chronological progression and ...
Metastasis, the major cause of cancer death, represents one of the major challenges in oncology. Scientists are still trying to understand the biological basis underlying the dissemination and outgrowth of tumor cells, why these cells can remain dormant for years, how they become resistant to the immune system or cytotoxic effects of systemic therapy, and how they interact with their new ...
Introduction. Cancer metastasis, or the systemic spread and growth of tumor cells throughout the body, is the principal cause of cancer-related deaths 1.Despite seventy years of drug development for cancer, survival rates for patients with metastatic disease remain abysmal, with five-year survival rates ranging from 5-30% across solid tumors 2.This low survival rate has persisted because ...
Metastasis causes most cancer deaths, yet this process remains one of the most enigmatic aspects of the disease. Building on new mechanistic insights emerging from recent research, we offer our perspective on the metastatic process and reflect on possible paths of future exploration.
The US cancer mortality rate declined by 29% from 1991 to 2017, with an average decline of 1.5% per year between 2013 and 2017. The steepest declines have been observed in metastatic melanoma (− ...
It is the spread of cancer cells to other (secondary) sites and their growth in these sites that can contribute to some cancer patients' sickness (morbidity) and deaths (mortality). The tumor metastatic process has been compared to a marathon. Tumor cells have to invade the solid tissues around the primary tumor site.
Major Finding: Molecular, cellular, and metabolic profiling of liver biopsies collected during resection of localized PDAC could predict metastatic outcome with high accuracy. Concept: Pre-metastatic livers from patients can predict future metastasis, liver vs. extrahepatic metastasis, and long-term survival in patients with no evidence of disease. Impact: Profiling liver biopsies at the time ...
Cancer metastasis, or the systemic spread and growth of tumor cells throughout the body, is the principal cause of cancer-related death 1. Despite 70 years of drug development for cancer, survival ...
Metastasis is the leading reason for the resultant mortality of patients with cancer. The past few decades have witnessed remarkable progress in understanding the molecular and cellular basis of this lethal process in cancer. The current article summarizes some of the key progress in this area and discusses the role of cell junctions, cell adhesions, epithelial-mesenchymal transition, angio ...
Journal of Cancer Research and Clinical Oncology - Kinase interacting with stathmin (KIS) is a serine/threonine kinase involved in RNA processing and protein phosphorylation. ... regulates the ID1-mediated enhancement of β-catenin to facilitate LUAD cell invasion and metastasis. Kinase interacting with stathmin (KIS) is a serine/threonine ...
New research from Edith Cowan University (ECU) is one step closer to understanding why uveal melanoma, the deadliest form of eye cancer, has such a high rate of metastasis. Uveal melanoma is a ...
Cancer that spreads from where it started to a distant part of the body is called metastatic cancer. For many types of cancer, it is also called stage IV (4) cancer. The process by which cancer cells spread to other parts of the body is called metastasis. When observed under a microscope and tested in other ways, metastatic cancer cells have ...
Most deaths from cancer are explained by metastasis, and yet large-scale metastasis research has been impractical owing to the complexity of in vivo models. Here we introduce an in vivo barcoding ...
A colorectal cancer metastasis (left half of the image) in the liver. Colorectal cancer cells (pictured in magenta) surrounded by other cells (in white) within the metastasis (microscopy image). ... Plexin and its counterpart semaphorin were previously known to the research community for their function in the nervous system, where the two ...
Introduction. Metastasis is the culmination of neoplastic progression. In their classic review, Hanahan and Weinberg describe six hallmarks of cancer. 1 Besides immortality, abnormal growth regulation, self-sufficient growth, evasion of apoptosis, and sustained angiogenesis, invasion and metastasis are identified as distinguishing characteristics. . However, although invasion through the ...
Background A substantial proportion of patients with metastatic clear cell renal cell carcinoma (ccRCC) cannot derive benefit from immune checkpoint inhibitor (ICI) plus anti-angiogenic agent combination therapy, making identification of predictive biomarkers an urgent need. The members of pleckstrin homology-like domain family A (PHLDA) play critical roles in multiple cancers, whereas their ...
Computational Systems Biology Approaches to Metastasis Research. The biological mechanisms underlying cancer metastasis occur at multiple biological scales. The ability to describe events across scales is needed to understand tumor cell dissemination in an integrated manner. For a metastatic tumor cell, these scales include genetic and ...
Sex matters in metastasis, but it has received little attention in research. Here, we highlight the emerging and important roles of biological sex in metastasis and advocate for mechanistic and ...